ParagonRx Release: Annual Review of Risk Evaluation and Mitigation Strategies and Risk Management Trends to be Presented in Complimentary Webcast
1/10/2012 9:00:32 AM
NEWARK, Del.--(BUSINESS WIRE)--There were abundant changes in 2011 related to pharmaceutical safe use and risk management that has industry professionals anticipating what is to come in 2012. ParagonRx, an inVentiv Health company, is pleased to announce a review of their annual analysis of trends, lessons learned, and best practices in Risk Evaluation and Mitigation Strategies (REMS) and risk management. This review will be addressed in a complimentary webinar presented by ParagonRx risk management experts on Wednesday, January 11, at 12 noon EST.
comments powered by